癌症患者静脉血栓栓塞症的预防
本文综述癌症患者静脉血栓栓塞症(VTE)的预防。VTE包括深静脉血栓和肺栓塞,是癌症患者致残和致死的重要原因。准确的风险评估、诊断和治疗对防止这一高危人群死亡至关重要。已开发多种预测癌症患者VTE的风险模型,掌握这些评分对肿瘤科医生很关键。特别关注亚组包括接受化疗的住院患者、肿瘤减灭术后患者及接受放疗的患者。多种新药可用于高危癌症患者的VTE预防,包括直接口服抗凝药(DOACs),无需其他方式所需的监测且口服给药,避免皮下注射的不适。
要点
- VTE包括深静脉血栓和肺栓塞,是癌症患者致残和致死的重要原因,可发生危及生命的并发症。
- 已开发多种预测癌症患者VTE的风险模型,掌握这些评分对肿瘤科医生至关重要。
- 需特别关注的亚组:接受化疗的住院患者、肿瘤减灭术后患者、接受放疗的患者。
- 高危癌症患者VTE预防可选直接口服抗凝药(DOACs),口服给药且无需其他方式所需的监测,避免皮下注射不适。
适用人群与场景
- 癌症患者,尤其接受化疗的住院患者、肿瘤减灭术后患者及接受放疗的患者。
处置流程与药物剂量
- 对癌症患者进行准确的风险评估,使用已开发的VTE风险模型识别高危患者。
- 对高危癌症患者可采用直接口服抗凝药(DOACs)预防VTE,口服给药,无需其他方式所需的监测。
研究设计与关键结果
- 综述指出VTE是癌症患者致残和致死的重要原因,准确的风险评估、诊断和治疗对防止死亡至关重要;已开发多种VTE风险模型,直接口服抗凝药(DOACs)可用于高危患者的预防。
对床旁实践的改变
- 对癌症患者应使用风险模型进行VTE风险评估,尤其关注接受化疗的住院患者、肿瘤减灭术后患者及放疗患者;高危者可考虑直接口服抗凝药(DOACs)预防,口服给药且无需其他方式所需的监测。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「证据类型、等级与局限」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Venous thromboembolism (VTE) is a major cause of both morbidity and mortality in patients with cancer. Venous thromboembolism, which includes both deep vein thrombosis and pulmonary embolism, affects a sizable portion of patients with malignancy and can have potentially life threatening complications. Accurate assessment of risk as well as diagnosis and treatment of this process is paramount to preventing death in this high risk population. Various risk models predictive of venous thromboembolism in patients with cancer have been developed, and knowledge of these rubrics is essential for the treating oncologist. Subgroups of particular interest are inpatients receiving chemotherapy, postoperative patients after surgical debulking, and patients undergoing radiotherapy. Numerous newer drugs have become available for the prevention of venous thromboembolism in patients with cancer who are at high risk of developing the disease. These include the class of drugs called direct oral anticoagulants, (DOACs) which do not require the same monitoring that other modalities have previously required and are taken by mouth, preventing the discomfort associated with subcutaneous strategies. The appropriate risk stratification and intervention to prevent venous thromboembolism are vital to the treatment of patients with cancer.
参考来源
- Guntupalli SR, Spinosa D, Wethington S, et al. Prevention of venous thromboembolism in patients with cancer. BMJ. 2023. PMID: 37263632. doi:10.1136/bmj-2022-072715
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。